Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Freisinger

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Inorganic Chemistry|February 28, 2006
Pyrazine as a building block for molecular architectures with PtIIMichael Willermann, Clodagh Mulcahy, Roland K O Sigel, et al.
European Heart Journal|February 5, 2015
Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherenceHolger Reinecke, Michael Unrath, Eva Freisinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2017
Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve ImplantationFlorian Lüders, Klaus Kaier, Gerrit Kaleschke, et al.
Stem Cells and Development|April 13, 2010
Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cellsChristopher Cramer, Eva Freisinger, Ryan K Jones, et al.
Journal of Cellular Physiology|July 17, 2010
Characterization of hematopoietic potential of mesenchymal stem cellsEva Freisinger, Christopher Cramer, Xiujin Xia, et al.
European Heart Journal|January 9, 2025
Hospitalized upper extremity artery disease patients: treatment and long-term outcomesLena Makowski, Christiane Engelbertz, Jeanette Köppe, et al.
Herz|November 18, 2020
[Medication-based secondary prevention in patients with peripheral arterial occlusive disease : An analysis based on secondary data]Katrin Gebauer, Kerstin Wintersohl, Rike Kraska, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 24, 2023
Contemporary Treatment and Outcome of Patients with Ischaemic Lower Limb Amputation: A Focus on Sex DifferencesLena Makowski, Christiane Engelbertz, Jeanette Köppe, et al.
Journal of Internal Medicine|September 2, 2024
Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin-K antagonists: A retrospective German claims data analysisChristiane Engelbertz, Ursula Marschall, Jannik Feld, et al.
Cytotherapy|June 29, 2014
Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parametersNasser M Malyar, Stefan Radtke, Khalil Malyar, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Inorganic Chemistry|February 28, 2006
Pyrazine as a building block for molecular architectures with PtIIMichael Willermann, Clodagh Mulcahy, Roland K O Sigel, et al.
European Heart Journal|February 5, 2015
Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherenceHolger Reinecke, Michael Unrath, Eva Freisinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2017
Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve ImplantationFlorian Lüders, Klaus Kaier, Gerrit Kaleschke, et al.
Stem Cells and Development|April 13, 2010
Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cellsChristopher Cramer, Eva Freisinger, Ryan K Jones, et al.
Journal of Cellular Physiology|July 17, 2010
Characterization of hematopoietic potential of mesenchymal stem cellsEva Freisinger, Christopher Cramer, Xiujin Xia, et al.
European Heart Journal|January 9, 2025
Hospitalized upper extremity artery disease patients: treatment and long-term outcomesLena Makowski, Christiane Engelbertz, Jeanette Köppe, et al.
Herz|November 18, 2020
[Medication-based secondary prevention in patients with peripheral arterial occlusive disease : An analysis based on secondary data]Katrin Gebauer, Kerstin Wintersohl, Rike Kraska, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 24, 2023
Contemporary Treatment and Outcome of Patients with Ischaemic Lower Limb Amputation: A Focus on Sex DifferencesLena Makowski, Christiane Engelbertz, Jeanette Köppe, et al.
Journal of Internal Medicine|September 2, 2024
Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin-K antagonists: A retrospective German claims data analysisChristiane Engelbertz, Ursula Marschall, Jannik Feld, et al.
Cytotherapy|June 29, 2014
Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parametersNasser M Malyar, Stefan Radtke, Khalil Malyar, et al.
Pageof 12